NECTIN4 Amplification Is Frequent in Solid Tumors and Predicts Enfortumab Vedotin Response in Metastatic Urothelial Cancer (2024) Klümper N, Tran NK, Zschäbitz S, Hahn O, Büttner T, Roghmann F, Bolenz C, et al. Journal article Development and Validation of a Prediction Model of Outcome After B-Cell Maturation Antigen-Directed Chimeric Antigen Receptor T-Cell Therapy in Relapsed/Refractory Multiple Myeloma. (2024) Gagelmann N, Dima D, Merz M, Hashmi H, Ahmed N, Tovar N, Oliver-Caldés A, et al. Journal article Inotuzumab Ozogamicin as Induction Therapy for Patients Older Than 55 Years With Philadelphia Chromosome-Negative B-Precursor ALL (2024) Stelljes M, Raffel S, Alakel N, Wäsch R, Kondakci M, Scholl S, Rank A, et al. Journal article Bosutinib in Resistant and Intolerant Pediatric Patients With Chronic Phase Chronic Myeloid Leukemia: Results From the Phase I Part of Study ITCC054/COG AAML1921. (2024) Brivio E, Pennesi E, Willemse ME, Huitema AD, Jiang Y, Van Tinteren HD, Van Der Velden VH, et al. Journal article Risk-Adapted Neoadjuvant Chemoradiotherapy in Rectal Cancer: Final Report of the OCUM Study (2023) Ruppert R, Junginger T, Kube R, Strassburg J, Lewin A, Baral J, Maurer CA, et al. Journal article Associations of a Breast Cancer Polygenic Risk Score With Tumor Characteristics and Survival (2023) Lopes Cardozo JM, Andrulis IL, Bojesen SE, Dörk T, Eccles DM, Fasching P, Hooning MJ, et al. Journal article Circulating Tumor DNA Profiling for Detection, Risk Stratification, and Classification of Brain Lymphomas (2023) Mutter JA, Alig SK, Esfahani MS, Lauer EM, Mitschke J, Kurtz DM, Kühn J, et al. Journal article Margetuximab Versus Trastuzumab in Patients With Previously Treated HER2-Positive Advanced Breast Cancer (SOPHIA): Final Overall Survival Results From a Randomized Phase 3 Trial (2023) Rugo HS, Im SA, Cardoso F, Cortes J, Curigliano G, Musolino A, Pegram MD, et al. Journal article Neuroendocrine Tumors and Peptide Receptor Radionuclide Therapy: When Is the Right Time? (2022) Hope TA, Pavel ME, Bergsland EK Journal article, Review article Tailored Immunotherapy Approach With Nivolumab in Advanced Transitional Cell Carcinoma (2022) Grimm MO, Schmitz-Dräger BJ, Zimmermann U, Grün CB, Baretton GB, Schmitz M, Foller S, et al. Journal article